Swiss drug companies report promising results from anti-COVID cocktail
By AFP Swiss pharma giant Roche announced Tuesday promising results from clinical trials of an anti-Covid cocktail developed with U.S. biotech firm Regeneron. The results of the Phase 3 trial showed that the combination of the antibodies casirivimab and imdevimab “reduced hospitalisation or death by 70 percent in non-hospitalised patients with COVID-19,” it said in…